What is SkinIO?
Based in Chicago, Illinois, SkinIO operates at the intersection of artificial intelligence and preventative medicine. The company provides a sophisticated service platform that empowers individuals to monitor their skin health proactively. By leveraging proprietary AI algorithms alongside oversight from licensed dermatologists, SkinIO bridges the gap between routine skin checks and clinical diagnostic accuracy. This digital health solution is designed to facilitate early detection of skin cancer, effectively transforming how patients and providers approach dermatological surveillance in a scalable, remote-first environment.
How much funding has SkinIO raised?
SkinIO has raised a total of $179K across 1 funding round:
Debt
$179K
Debt (2021): $179K with participation from PPP
Key Investors in SkinIO
PPP
Public-Private Partnership
What's next for SkinIO?
Following this major strategic investment, SkinIO is well-positioned to accelerate its operational scaling and enhance its diagnostic capabilities. The late-stage funding context suggests a transition toward broader market penetration and the potential expansion of its clinical partnerships. As the company matures, the focus will likely shift toward integrating its AI-driven insights into broader healthcare ecosystems, optimizing patient outcomes, and refining its service delivery model to meet the growing demand for accessible, high-quality skin cancer screening tools. The firm remains a critical player in the digital health sector, poised to leverage its technological moat to capture further market share.
See full SkinIO company page
